Shizuoka, Japan

Eriko Murata

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eriko Murata. Retrieved from https://idiyas.com/inventor/eriko-murata-993v3n6a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eriko Murata: Innovator in Antibody Research

Introduction

Eriko Murata is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of antibody research, particularly in the development of specific Fc antibodies. Her innovative work has led to advancements in therapeutic applications.

Latest Patents

One of her notable patents is the "Mouse FcγammaRII-specific Fc antibody." This invention involves the discovery of numerous Fc variants that exhibit remarkably increased binding activity and selectivity for mouse FcγRII. The invention was achieved by introducing amino acid alterations to the Fc region, showcasing her expertise in molecular biology.

Career Highlights

Eriko Murata has been associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her role at the company has allowed her to focus on innovative research and development in the field of antibodies.

Collaborations

Throughout her career, Eriko has collaborated with talented individuals such as Tomoyuki Igawa and Futa Mimoto. These collaborations have further enhanced her research and contributed to the success of her projects.

Conclusion

Eriko Murata's contributions to antibody research and her innovative patents highlight her as a key figure in the scientific community. Her work continues to influence advancements in therapeutic applications, making her a notable inventor in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…